IUPUI behavioral neuroscientist receives international award for alcoholis... (GABA receptor changes that occur over re...)

IUPUI behavioral neuroscientist receives international award for alcoholism research

Date:5/9/2011

GABA receptor changes that occur over repeated binge drinking episodes.

At the IBANGS meeting in Rome, Boehm will present details of an arm of his study that focuses on alcoholic consumption by female mice. Initial findings indicate that hormonal status appears to modify the role of GABA receptors in binge alcohol consumption. Brain response to alcohol may vary in females depending on when in the month it is consumed. School of Science doctoral candidate Laverne Meln conducted many of the experiments related to this work.

Two other School of Science students, doctoral candidates Eileen Moore and David Linsenbardt, will accompany Boehm to Rome where they will present findings on their research in the Boehm lab. Moore's work focuses on the influence of genetics on adolescent alcohol sensitivity and how it differs from adult sensitivity in mice. Linsenbardt is studying the role of genetic factors in the behavior and brain adaptation to repeated alcohol exposure in mice.

Mentoring is a high priority for Boehm, both at the graduate and undergraduate levels. Four graduate students work in his lab as do six undergraduates.

"The one-on-one nature of mentoring engages students in the scientific enterprise. On the graduate level you instruct students in experiment design, communication of research findings and critical thinking skills so that they ultimately become colleagues. Mentoring undergraduates is a real extension of classroom teaching, especially because this is a unique opportunity to get students interested in science," said Boehm who teaches both undergraduates and graduate courses in the School of Science.

In addition to behavioral neuroscience, Boehm's areas of expertise include behavioral genetics, molecular genetics, pharmacology, and developmental research. He has published 31 peer-reviewed papers. His research is supported by a $1.25 million grant, awarded in 2009, by the National Institute on Alcohol Abuse and
'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University-Purdue University Indianapolis School of Science
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. IUPUI faculty member to receive national innovative vision research award
2. Molecules made by IUPUI students may have potential to cure diseases
3. International recognition for IUPUI work to improve breast cancer detection
4. Behavioral Therapy May Reduce Tourette Tics, Symptoms
5. Babies Persistent Fussiness Could Mean Behavioral Woes Ahead
6. Springer launches new journal, Translational Behavioral Medicine: Practice, Policy, Research
7. Prenatal exposure to certain pollutants linked to behavioral problems in young children
8. Improved behavioral health needed to respond to rising number of suicides among US Armed Forces
9. Brief Behavioral Counseling May Help Seniors Sleep
10. Could Cell Phones Raise Odds for Behavioral Woes in Kids?
11. Perspectives on improving patient care: Genetics, personalized medicine, and behavioral intervention

Post Your Comments:

Related Image:

IUPUI behavioral neuroscientist receives international award for alcoholism research

(Date:5/21/2013)... CA (PRWEB) May 21, 2013 DISCcert ... materials showing how to use 17 DISC applications at ... is a natural progression. , The July 25 & ... the top 17 ways of applying DISC. The time-tested, ... certified graduates. The user-friendly DISC training materials ...

(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... to protecting the rights of victims injured by defective ... Journal of Bone & Joint Surgery on May 15, ... can be used to identify complications that occur in ... any symptoms of failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) ...

(Date:5/21/2013)... The Orsiro stent, which is a novel stent ... non-inferiority to the Xience Prime everolimus-eluting stent for ... loss at nine months in the results of ... , The BIOFLOW-II substudy used intravascular ultrasound (IVUS) ... neointimal hyperplasia and stent apposition at nine months ...

(Date:5/21/2013)... Hillsboro, OR (PRWEB) May 21, 2013 ... curing systems at the 20th Annual IMI European ... As a proven market leader, Phoseon continues to invest ... while accelerating the adoption of UV LED curing in ... of product families on the market offering both air ...

(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...

Breaking Medicine News(10 mins):Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3 Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2 Health News:Researchers find genetic risk factor for pulmonary fibrosis 2

[0] DISCcert Offers 17 Applications in Coming DISC Certification [0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants [0] Biodegradable stent proves non-inferior to drug-eluting stent [0] Phoseon Technology Presents the Leading UV LED Curing Solutions at IMI European Ink Jet Conference [0] Researchers find genetic risk factor for pulmonary fibrosis

... The Lancet Supports Cardio-Protective Potential of Aleglitazar - , ... will start Phase III clinical investigations for aleglitazar, its innovative ... morbidity and mortality in high risk patients with type 2 ... II SYNCHRONY study published today in The Lancet(1) ...

... , Customizable Survival Kit Offers One Stop for ... Local Healthcare Market Drivers and Health Plan Trends ... a leading provider of managed care market intelligence, ... shifts in membership at the state level than ...

... the company that will become public from the planned ... today filed a second amendment to its Form 10 ... that includes information about its post-spin board of directors ... under a consent decree for its Alaris(R) infusion products. ...

... United Spinal Association ( www.UnitedSpinal.org ) presents the ... ) , the region,s premiere lifestyle-enhancing Expo designed to ... aging Americans. , , The Independence Expo will ... at the Suffolk Community College Sports & Exhibition Complex in ...

... PSI-7851 was generally safe and well tolerated in Phase 1a ... results from single ascending and multiple ascending dose trials are ... June 9 Pharmasset, Inc. (Nasdaq: VRUS ) ... study and begun dosing in a multiple ascending dose trial ...

... ... its Multilayer Aneurysm Repair System (MARS) has received CE Mark approval for treating patients ... ... announced today that it has received CE Mark approval for the commercial sale of ...

Cached Medicine News:Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 2 Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 3 Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 4 Health News:Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack 5 Health News:Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment 2 Health News:CareFusion Announces Board of Directors, Progress on Alaris Consent Decree 2 Health News:CareFusion Announces Board of Directors, Progress on Alaris Consent Decree 3 Health News:CareFusion Announces Board of Directors, Progress on Alaris Consent Decree 4 Health News:United Spinal Association Presents The 2009 Independence Expo: Improving Life for the Disabled and the Aging 2 Health News:Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients 2 Health News:Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients 3 Health News:Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients 4 Health News:Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms 2

Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment CareFusion Announces Board of Directors, Progress on Alaris Consent Decree United Spinal Association Presents The 2009 Independence Expo: Improving Life for the Disabled and the Aging Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms

(Date:5/21/2013)... 2013 Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, municipalities, healthcare and first ... today announced that the Company accepted a commitment ... Facility subject to certain terms and conditions and ... no assurances can be given that this transaction ...

(Date:5/21/2013)... 21, 2013 Tom Daulton, CEO of Mammotome, a division ... Year by the Cincinnati chapter of ... by another local top executive who is also a breast ... Ethicon Endo-Surgery in March of 2010. Daulton will be presented ... presented by Huntington Bank, on May 22. The ...

(Date:5/21/2013)... Kepner-Tregoe (KT), the global capability development ... Chris Geraghty has been ... than 20 years serving the industrial sector, holding ... succeeds Ray Baxter , who ... the Board and CEO. (Logo: ...

[0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results [0] Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year [0] Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer

... 14, 2011 /PRNewswire / -- Nephros, Inc. (OTC Bulletin Board: ... three months ended September 30, 2011. Recent ... associated with Rights Offering to be exercised; Received initial ... Hemodiafiltration System in U.S. Financial ...

... 14, 2011 Landauer, Inc. (NYSE: LDR ... radiation monitoring and the leading domestic provider of outsourced ... all of the outstanding equity interests of IZI Medical ... a purchase price of approximately $93 million. IZI Medical ...

Cached Medicine Technology:Nephros Reports Third Quarter 2011 Financial Results 2 Nephros Reports Third Quarter 2011 Financial Results 3 Nephros Reports Third Quarter 2011 Financial Results 4 Nephros Reports Third Quarter 2011 Financial Results 5 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 2 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 3 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 4 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 5 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 6

Nephros Reports Third Quarter 2011 Financial Results Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • Not available with casters • With Tubular Base....

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....

Medicine Products:

4V63 4V61-R 4V42-R 4V58-R